1. The Pharmaceutical Medicine Year That Was

   • Anthony W. Fox

   Commentary 24 August 2012 Pages: 351 - 352

2. The Future Contribution of China to Medicines Development and Human Subjects Protections

   • Francis P. Crawley

   Special Section on Medicines Development in China 24 August 2012 Pages: 353 - 354

3. China as a Growing Research Base for Innovation in Medicines Development

   • Michael Humphries
   • Detlef Niese
   • Paul Dai

   Special Section on Medicines Development in China 24 August 2012 Pages: 355 - 359

   

4. Current Status of the Implementation of Good Clinical Practice in China

   • Cai Cao

   Special Section on Medicines Development in China 24 August 2012 Pages: 361 - 366

   

5. Human Subjects Protections in Clinical Drug Trials in China

   • Jiaqi Xu
   • Benfu Li
   • Yali Cong

   Special Section on Medicines Development in China 24 August 2012 Pages: 367 - 372

   

6. National and International Collaboration in Chinese Medical Academic Research

   • Jinhong Hu
   • Jie Chen
   • Kenji Hirajama

   Special Section on Medicines Development in China 24 August 2012 Pages: 373 - 378

   

7. Report of a Workshop on ‘Human Subjects Protections — Developing Ethical Review Management’

   • Haitao (Heidi) Liu
   • Yali Cong
   • Francis P. Crawley

   Special Section on Medicines Development in China 24 August 2012 Pages: 379 - 382

8. 6th Annual Meeting of the Safety Pharmacology Society

   • Sue Pochon

   Meeting Report 24 August 2012 Pages: 383 - 384

   

9. Risk Management Plans

   • Rosie Stather

   Meeting Report 24 August 2012 Pages: 385 - 387

   

10. Forum

    Update 24 August 2012 Pages: 389 - 392

11. Summary of Recent Deal Activity

    Update 24 August 2012 Pages: 393 - 399

    

12. Major Pharmaceutical Conferences

    Update 24 August 2012 Pages: 401 - 402

    

13. Society of Pharmaceutical Medicine

    SPM News 24 August 2012 Pages: 403 - 405

14. Directory

    BriefCommunication 24 August 2012 Pages: 407 - 409